Jivi Intravenous and Nevirapine Extended-Release Tablets
Determining the interaction of Jivi Intravenous and Nevirapine Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Jivi, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Obizur
Synonyms: Jivi
Generic Name: nevirapine
Brand name: Viramune, Viramune XR
Synonyms: Nevirapine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Jivi Intravenous-Nevirapine Oral Suspension
- Jivi Intravenous-Nevirapine Suspension
- Jivi Intravenous-Nevirapine Tablets
- Jivi Intravenous-New Day
- Jivi Intravenous-New Terocin
- Jivi Intravenous-Nexa Plus
- Nevirapine Extended-Release Tablets-Jolessa
- Nevirapine Extended-Release Tablets-Jolessa extended-cycle
- Nevirapine Extended-Release Tablets-Jolivette
- Nevirapine Extended-Release Tablets-Jornay PM
- Nevirapine Extended-Release Tablets-Juleber
- Nevirapine Extended-Release Tablets-Juluca